Sanfetrinem cilexetil

N/A

Report date: 2024/08/30 15:26:44
NME

Base Information

Drug NameSanfetrinem cilexetil
Drug Alias Name山费培南酯GV-118819
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsTuberculosis, PulmonaryTuberculosisBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Africa
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesGlaxosmithkline Plc
Inactive CompaniesN/A
Active IndicationsTuberculosis, PulmonaryTuberculosis
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksKEGG